| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |